(Q43272430)

18 November 2017

Pathological definition of triple negative breast cancer (English)

1 reference

18 November 2017

1

Giuseppe Viale

1 reference

18 November 2017

Luca Bottiglieri

2

1 reference

18 November 2017

1 September 2009

1 reference

European Journal of Cancer

18 November 2017

1 reference

18 November 2017

45 Suppl 1

1 reference

18 November 2017

5-10

1 reference

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Triple-negative breast cancer: therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Triple negative tumours: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

The prognostic importance of triple negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Are triple-negative tumours and basal-like breast cancer synonymous?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

How basal are triple-negative breast cancers?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Refinement of breast cancer classification by molecular characterization of histological special types

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of anti

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Prognostic markers in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2809%2970011-5

7 January 2021

10.1016/S0959-8049(09)70011-5

Identifiers

DOI

1 reference

18 November 2017

1 reference

PubMed ID

19775600